Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold ...

Merck, known as MSD outside the US and Canada, got approval for Vaxneuvance from the FDA in July – a month after Pfizer upped the ante in the competitive stakes with a green light for Prevnar-20 ...